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Background: One of the infections that mimic tuberculosis (TB) is paragonimiasis (PRG), a foodborne
parasitic disease caused by lung flukes of the genus Paragonimus. In the northeastern states of India, TB and
PRG are endemic; however, PRG is rarely included in the differential diagnosis of TB.
Objective: To address limited evidence on the dual burden of TB and PRG in northeastern India, we aimed to
document the prevalence of PRG among TB patients using sputum smear, stool examination for children
B15 years and ELISA.
Design: A cross-sectional study of patients receiving TB treatment in the Me´decins Sans Frontie`res (MSF)-
supported TB programme in Mon district, in collaboration with the Regional Medical Research Centre
(RMRC), Dibrugarh, Assam, between November 2012 and December 2013.
Results: Of 96 patients screened between November 2012 and December 2013, three (3%) had pulmonary
PRG and were successfully treated with praziquantel.
Conclusions: PRG should be considered in the TB diagnostic algorithms in PRGTB dual burden areas. In case
of TBPRG co-infection, it is preferable to treat PRG first followed by anti-TB treatment a few days later.
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Introduction
Tuberculosis (TB) is one of the most ancient communic-
able diseases, ranked as the leading cause of death among
infectious disease, along with HIV/AIDS. In 2014, an
estimated 9.6 million people developed TB and 1.5 million
died from the disease (1). The high mortality and morbidity
of TB, especially multidrug-resistant TB, led to reinforced
efforts to fight the TB pandemic, including policy discus-
sions around sustainable developmental goals (2) and
End TB Strategy (3). These initiatives are being incorpo-
rated into national and international policies and strate-
gies. The TB clinical algorithms are being revised in most
affected countries to reflect new tools allowing accurate
diagnosis, new drugs and treatment regimens. However,
accurate diagnosis continues to be challenging as TB is a
multisystemic disease with myriad manifestations; it may
masquerade as many other diseases or conditions and thus
differential diagnosis based on the local epidemiology is
essential.
One of the infections that mimic TB is paragonimiasis
(PRG), a parasitic disease caused by lung flukes of the
genus Paragonimus spp. (4). Both diseases are similar in
clinical presentation including chronic cough, dyspnoea,
haemoptysis and chest pain; however, the mode of
transmission is different. TB is an airborne infection, and
PRG is a food-borne trematode infection, usually caused
after consumption of raw, pickled or insufficiently cooked
freshwater crustaceans (crabs and crayfish) containing
encysted metacercariae of the parasite. PRG is considered
a rare and rather unusual condition of limited public
health importance, and thus, it is widely neglected (5). The
microscopic examination for PRG is cumbersome and has
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low sensitivity (6), making the PRG diagnosis extremely
challenging in resource-limited countries. In the north-
eastern states of India, both TB and PRG have been
present, and several endemic foci have been discovered
(3, 4, 6). The prevalence of PRG ranged from 7 to 15%
(3, 4) in the general population and around 50% in TB
patients (7); however, PRG is often underdiagnosed.
Misdiagnosis of PRG may not only delay the initiation
of appropriate treatment but also pose an unnecessary
burden of long and toxic TB treatment on the patient (8).
Serologic testing for PRG with high specificity has been
previously found effective in population based screening
in India (9). The current recommended regimen for PRG
is a 3-day short course with praziquantel (10). In cases of
TBPRG co-infection, TB treatment failure may be
wrongly diagnosed if lung symptoms persist.
Between 2010 and 2014, Me´decins Sans Frontie`res
(MSF)/Doctors Without Borders had collaborated with
Mon District Hospital, Nagaland, in providing inte-
grated care to TB patients (11). Based on empirical
observations of relatively high numbers of negative acid-
fast bacilli sputum smears among patients with TB and
based on the local epidemiology, we hypothesised that
PRG may be included in the programme’s TB diagnostic
algorithm.
Methods
We conducted a cross-sectional study to assess the pre-
valence of PRG in patients receiving TB treatment in the
MSF-supported TB programme in Mon district, in
collaboration with the Regional Medical Research Centre
Patients enrolled in Tuberculosis (TB) Program 
Lab investigations for AFB (Sputum smear microscopy)
and Paragonimiasis (Sputum smear microscopy, stool
examination for children <15 years, ELISA)  
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Fig. 1. Diagnostic and treatment algorithm for tuberculosis patients co-infected with paragonimiasis. AFB: acid-fast bacilli for
Mycobacterium tuberculosis (TB); ELISA: the enzyme-linked immunosorbent assay; PRG: paragonimiasis; ATT: anti-TB
treatment.
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(RMRC), Dibrugarh, Assam, between November 2012
and December 2013. A diagnostic and treatment algo-
rithm was followed (Fig. 1). Sputum smear microscopy,
stool examination for childrenB15 years and ELISAwere
carried out to identify PRG and TB in patients, and
appropriate treatments with anti-TB drugs and/or prazi-
quantel were offered free of charge.
The study received approval from the MSF Ethics
Review Board, Geneva, Switzerland. Informed consent
was obtained from all study participants.
Results
Ninety-six patients who had given consent were screened
of whom three (3%) had pulmonary PRG, including
one with HIV co-infection. Of these three PRG patients,
two had smear-positive TB with no improvement in
clinical condition with TB treatment; however, the third
was diagnosed as smear-negative TB. Subsequent treat-
ment with praziquantel led to substantial improvement of
symptoms and eventually to cure among all three patients.
Discussion
This study provided some limited but important evidence
that PRG may be integrated into the TB diagnostic
algorithms (Table 1) in PRG-endemic areas (4). We have
constructed a simple diagnostic and treatment algorithm
using a limited number of diagnostic tests and medicines.
Praziquantel may have pharmacological interactions with
TB medicines (12). In case of TBPRG co-infection, it is
preferable to treat PRG first followed by anti-TB treatment
a few days later. If the diagnosis of PRG has been made
after TB treatment initiation, a 4-week period may be
considered before the PRG treatment initiation.
A 2-dose/1-day regimen with triclabendazole may be
preferred over the 3-day praziquantel regimen for simpli-
city as this may ensure higher adherence to treatment.
Triclabendazole may be shipped free of charge upon
application from ministries of health to the World Health
Organization, while mass drug administration may be
considered in communities where cases of PRG are
significantly clustered (10).
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Paper context
Tuberculosis (TB) and paragonimiasis (PRG) are similar in
clinical presentation; however, the modes of transmission are
different. In the northeastern states of India, both TB and
PRG are present but PRG is underdiagnosed. We documen-
ted the prevalence of PRG among TB patients (3/96) in the
Me´decins Sans Frontie`res (MSF)-supported TB programme
in Mon district (20122013) using sputum smear, stool
examination for childrenB15 years and ELISA. Our study
indicates PRG may be integrated into the TB diagnostic
algorithms in PRG-endemic areas.
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